Considerations in the Rationale, Design and Methods of the Strategic Timing of AntiRetroviral Treatment (START) Study
Clinical Trials - United Kingdom
doi 10.1177/1740774512440342
Full Text
Open PDFAbstract
Available in full text
Date
April 30, 2012
Authors
Publisher
SAGE Publications